NanoBioSensor research focuses on developing innovative technologies that have the ability to make significant contributions in the arenas of human and animal disease marker detection, promising therapeutic compound identification and analysis, nano- and biomaterials characterization, and biocatalyst development. These technologies take the form of nanometrically engineered, biologically active surfaces, or liquid-solid interfaces, and the tools necessary to characterize them. The molecular structure and properties of the interface are determined through careful analysis, which is the first and most critical step in assessing target molecule binding specificity and ultimately the interface's potential to serve as a sensor platform. These studies are central to gaining insights into structure-function relationships, and set the stage for modifying the surface architecture to advance performance.
|click to here view larger image|
Understanding the surface chemistry at liquid-solid interfaces is a key component to the success of the group's core nanobiosensor research and will lead to discoveries in such diverse areas as fuel cells, nanoelectronic devices, chip-scale diagnostic platforms, chemical interaction databases, tissue replacement, and novel detection strategies. Knowledge gained in this area allows us to fine tune the chemistries at the heart of diagnostic and screening platforms, subsequently leading to the development of cutting edge diagnostic tools. These breakthroughs set the stage for vital scientific advances, while simultaneously providing significant opportunities for the State of Utah to strengthen its commercial position in the fast-growing and technologically critical field of nanotechnology.